A modified Delphi to define drug dosing errors in pediatric critical care

Nadia Roumeliotis1,2,3, Eleanor Pullenayegum4,5, Paula Rochon6,7,8

  • 1Department of Critical Care Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, Canada. nadia.roumeliotis@gmail.com.

BMC Pediatrics
|October 22, 2020
PubMed

Insights

Defining pediatric drug dosing errors is complex. Experts agreed that dosing over 10% above or below the reference range is typically an error, guiding clinical practice and quality improvement.

Area of Science:

  • Pediatric Critical Care Medicine
  • Clinical Pharmacology
  • Medication Safety

Background:

  • A globally accepted definition for dosing errors in adult and pediatric practice is lacking.
  • Existing definitions of pediatric dosing errors exhibit significant variability in the literature.
  • This variability complicates accurate identification and reporting of medication errors in critically ill children.

Purpose of the Study:

  • To develop a clinician-based framework for defining drug dosing errors in critically ill children.
  • To establish a set of guiding principles for identifying dosing errors.
  • To determine consensus-based thresholds for what constitutes a dosing error across various drug classes and clinical scenarios.

Main Methods:

  • A nationwide, three-stage modified Delphi method was employed from May to December 2019.
  • Expert participants included Canadian pediatric intensive care unit (PICU) physicians, pharmacists, and nurses with at least 5 years of experience.
  • Outcomes focused on underlying principles of drug dosing and agreed-upon error thresholds relative to a reference range.

Main Results:

  • Forty-four experts participated, with high response rates across all three Delphi rounds (95%, 86%, 84%).
  • Consensus was reached on 13 of 15 principles and 23 of 30 error thresholds.
  • Key agreements included recognizing intercepted overdoses, under-dosing of critical medications, and dosing deviations of 50% or more as errors; however, a 10% deviation was generally considered an error threshold.

Conclusions:

  • Defining dosing errors in pediatric critical care is complex, with expert clinicians expressing uncertainty in certain scenarios.
  • For most intermittent medications, dosing outside a 10% range (above or below) was deemed an error, though context and drug properties were influential.
  • This consensus-derived threshold aims to standardize clinical dosing, reporting, and enhance drug quality improvement initiatives in pediatric critical care.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
130
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
126
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
155
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
155
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
103
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
91